Skip to main content
Year archive

CELL BIOTECH CO ., LTD — 2022 filings

All 22 regulatory filings released by CELL BIOTECH CO ., LTD (049960) in 2022, sourced directly from the official regulator.

22 Filings
2022 Period
2022 filings (22)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-12-01 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2022
2022-11-08 Korean
신탁계약해지결과보고서
Transaction in Own Shares
2022-08-18 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2022
2022-08-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-06-10 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares
2022-05-19 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-10 Korean
소속부변경
Regulatory Filings
2022-04-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-30 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-22 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-22 Korean
주주총회소집공고
AGM Information
2022-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-15 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-03-02 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-02-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-15 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-02-15 Korean